نتایج جستجو برای: relapsed hodgkin lymphoma

تعداد نتایج: 117560  

2011
Jonathan W. Friedberg Julie M. Vose Jennifer L. Kelly Faith Young Steven H. Bernstein Derick Peterson Lynn Rich Susan Blumel Nicole K. Proia Jane Liesveld Richard I. Fisher James O. Armitage Steven Grant John P. Leonard

Given the significant activity and tolerability of bendamustine, rituximab, and bortezomib in patients with relapsed indolent and mantle cell non-Hodgkin lymphoma, and laboratory studies suggesting synergistic activity, we conducted a multicenter phase 2 study of the bendamustine/ bortezomib/rituximab combination. Patients with relapsed or refractory indolent and mantle cell lymphoma with adequ...

Journal: :medical journal of islamic republic of iran 0
farzad izadi iran university of medical science, fellowship of laryngology, department of otolaryngology, head and neck surgery, uniسازمان اصلی تایید شده: دانشگاه علوم پزشکی ایران (iran university of medical sciences) ehsan parvas iran university of medical science, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی ایران (iran university of medical sciences) vita derakhshandeh department of otolaryngology, head and neck surgery, iran university of medical science, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی ایران (iran university of medical sciences)

primary non-hodgkin lymphoma of the larynx is rare, accounting for less than 1% of all laryngeal neoplasms. fewer than 100 cases have been reported in the literatureand to our knowledge this may be the first reported case of laryngeal non hodgkin lymphoma presented with hoarseness, aortic aneurysm, hepatitis b and skin rashes.

Journal: :British journal of haematology 2007
Nicolas Mounier Michele Spina Christian Gisselbrecht

Patients infected with human immunodeficiency virus (HIV) are at greater risk of developing non-Hodgkin lymphoma than the general population and aggressive B-cell lymphoma has become one of the most common of the initial acquired immunodeficiency syndrome (AIDS)-defining illnesses. This review considers the prognostic factors and new approaches to the treatment of patients with AIDS-related lym...

2015
Hee Kyung Kim Seong Mi Moon Ji Hoon Moon Jee Eun Park Seonggyu Byeon Won Seog Kim

TO THE EDITOR: [Abstract] The treatment outcome of relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma (ENKL) is poor. Brentuximab vedotin, an anti-CD30 antibody-drug conjugate, has recently been approved for the treatment of relapsed Hodgkin’s lymphoma and anaplastic large-cell lymphoma (ALCL). We report on a case of a 63-year-old man who presented with multiple skin lesions,...

Journal: :Journal of Ayub Medical College, Abbottabad : JAMC 2016
Muhammad Azhar Hafeez Ud Din Iqbal Muhammad Shoaib Naiyar Hashmi Farhan Akhtar

BACKGROUND Epstein-Barr virus plays an important role in pathogenesis of Hodgkin lymphoma. The first patient with Epstein-Barr positive Reed Sternberg cells was described in 1985. Since then association between Epstein-Barr virus and Hodgkin lymphoma has been shown in many parts of the world and its occurrence shows significant variation from continent to continent and from country to country. ...

Journal: :international journal of hematology-oncology and stem cell research 0
zohreh sanaat associate professor of hematology-oncology, hematology-oncology research center, tabriz university of medical science, tabriz, iran. seyed-mohammad tavangar professor of pathology, pathology department, shariati hospital, tehran university of medical science, tehran, iran. jalil vaez gharamaleki professor of hematology-oncology, hematology-oncology research center, tabriz university of medical science, tabriz, iran. iraj aswadi kermani professor of hematology-oncology, hematology-oncology research center, tabriz university of medical science, tabriz, iran. jamal eivazi ziae associate professor of hematology-oncology, hematology-oncology research center, tabriz university of medical science, tabriz, iran. alireza nikanfar associate professor of hematology-oncology, hematology-oncology research center, tabriz university of medical science, tabriz, iran.

background: lymphomas are a group of malignancies affecting b, t and nk cells. cox-2 enzyme is one of the known inflammatory factors which increase in the inflammation process. increase in cox-2 expression inhibits apoptosis and increases tumor cells invasion and angiogenesis. increase in the cox-2 gene expression is seen in a group of cancers .specific cox-2 inhibition also can be beneficial i...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید